ALITRECUTAN caps moll 30 mg 30 pce
7680688180022
CH-68818
D11AH04
10.04.0.
Reimbursement limitations:
ALITRECUTAN
ALITRECUTAN est indiqué chez l'adulte souffrant d'un eczéma sévère des mains réfractaire à la thérapie, …
1 / 3
google
Details
- Product number
- 6881802
- CPT
- -
- Packaging group
- 30
- Unit
- Kapsel(n)
- Composition
- alitretinoinum 30 mg, sojae oleum raffinatum 261.444 mg, sojae oleum partim hydrogenatum 17.388 mg, oleum vegetabile hydrogenatum, glyceroli monostearas 40-55, triglycerida media, int-rac-alpha-tocopherolum, Kapselhülle: gelatina, glycerolum, sorbitolum liquidum non cristallisabile corresp. sorbitolum 17.88 mg, titanii dioxidum, E 172 (flavum), aqua purificata, pro capsula.
Articles (1)
Alitrecutan 30 mg, Weichkapseln
Weichkapseln
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
261.444 MG | Substance | HBESI |
|
(N/A)
|
17.388 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
17.88 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 250.95
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/09/2023
Authorization holder
Dermapharm AG
6331 Hünenberg
Authorization information
- Swissmedic authorization number
- 68818
- Drug name
- Alitrecutan, Weichkapseln
- Galenic form
- KAPWE
- ATC Code
- D11AH04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 19/01/2023
- Authorization expiration date
- 18/01/2028
- IT number
- 10.04.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ALITRECUTAN caps moll 30 mg 30 pce
- Description (DE)
- ALITRECUTAN Weichkaps 30 mg 30 Stk
- Market launch
- 19/01/2023
- Narcotic (BTM)
- No